Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

February
01
2024

Sensus Healthcare Announces Retirement of Director Samuel O’Rear

BOCA RATON, Fla., Feb. 01, 2024 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that Samuel O’Rear will…

January
30
2024

Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024

BOCA RATON, Fla. , Jan. 30, 2024 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a…

January
23
2024

Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million

Ships more than 60 SRT units in 2023To report full financial results and hold conference call on February 8th BOCA RATON, Fla. , Jan. 23, 2024 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device…

January
03
2024

Is Mohs Surgery the Best Treatment Option for You?

For many skin cancer patients, going through surgery can be a daunting experience. However, when it comes to treating skin cancer, Mohs surgery has proven to be one of the most effective methods. It’s a…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy